top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes [[electronic resource]]
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes [[electronic resource]]
Pubbl/distr/stampa [Washington, D.C.] : , : [U.S. G.P.O.], , [2012]
Descrizione fisica 1 online resource (140 unnumbered pages)
Soggetto topico Drugs - Prices - Law and legislation - United States
Prescription pricing - Law and legislation - United States
Medical instruments and apparatus - Prices - United States
Generic drugs - Prices - United States
User charges - Law and legislation - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910702028003321
[Washington, D.C.] : , : [U.S. G.P.O.], , [2012]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes
Pubbl/distr/stampa [Washington, D.C.] : , : [U.S. Government Publishing Office], , 2017
Descrizione fisica 1 online resource (86 unnumbered pages)
Soggetto topico Drugs - Prices - Law and legislation - United States
Prescription pricing - Law and legislation - United States
Medical instruments and apparatus industry - Law and legislation - United States
Generic drugs - Prices - United States
Biologicals - Law and legislation - United States
User charges - Law and legislation - United States
Soggetto genere / forma Statutes and codes.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910706512203321
[Washington, D.C.] : , : [U.S. Government Publishing Office], , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
An Act to Make Corrections with Respect to Food and Drug Administration User Fees [[electronic resource]]
An Act to Make Corrections with Respect to Food and Drug Administration User Fees [[electronic resource]]
Pubbl/distr/stampa [Washington, D.C.] : , : [U.S. G.P.O.], , [2012]
Descrizione fisica 1 online resource (2 unnumbered pages)
Soggetto topico Drugs - Prices - Law and legislation - United States
Prescription pricing - Law and legislation - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910702251803321
[Washington, D.C.] : , : [U.S. G.P.O.], , [2012]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 : report (to accompany H.R 5133)
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 : report (to accompany H.R 5133)
Pubbl/distr/stampa [Washington, D.C.] : , : [U. S. Government Publishing Office], , 2020
Descrizione fisica 1 online resource (15 pages)
Collana Report / 116th Congress, 2d session, House of Representatives
Soggetto topico Prescription pricing - Law and legislation - United States
Competition, Unfair - United States
Competition, Unfair
Prescription pricing - Law and legislation
Soggetto genere / forma Legislative materials.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
Record Nr. UNINA-9910715216403321
[Washington, D.C.] : , : [U. S. Government Publishing Office], , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation [[electronic resource] ] : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007
Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation [[electronic resource] ] : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007
Pubbl/distr/stampa Washington : , : U.S. G.P.O., , 2008
Descrizione fisica vi, 311 pages : digital, PDF file
Soggetto topico Prescription pricing - Law and legislation - United States
Medical instruments and apparatus industry - Law and legislation - United States
Pediatric pharmacology - United States
Drugs - Safety measures - Government policy - United States
User charges - Law and legislation - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation
Record Nr. UNINA-9910697826103321
Washington : , : U.S. G.P.O., , 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug Discount Program: characteristics of hospitals participating and not participating In the 340B program
Drug Discount Program: characteristics of hospitals participating and not participating In the 340B program
Pubbl/distr/stampa Washington, DC : , : U.S. Government Accountability Office, , 2018
Descrizione fisica 1 online resource (31 pages)
Soggetto topico Drugs - Prices - Law and legislation - United States
Prescription pricing - Law and legislation - United States
Drug accessibility - Law and legislation - United States
Hospitals - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug discount program
Record Nr. UNINA-9910717276803321
Washington, DC : , : U.S. Government Accountability Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to congressional requesters
Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to congressional requesters
Pubbl/distr/stampa [Washington, D.C.] : , : United States. Government Accountability Office, , 2018
Descrizione fisica 1 online resource (iii, 62 pages) : illustrations
Soggetto topico Drugs - Prices - Law and legislation - United States
Drug accessibility - Law and legislation - United States
Prescription pricing - Law and legislation - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug discount program
Record Nr. UNINA-9910717277103321
[Washington, D.C.] : , : United States. Government Accountability Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives / / / statement of Debra A. Draper
Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives / / / statement of Debra A. Draper
Pubbl/distr/stampa [Washington, D.C.] : , : United States Government Accountability Office, , 2018
Descrizione fisica 1 online resource (9 pages)
Collana Testimony
Soggetto topico Prescription pricing - Law and legislation - United States
Drug accessibility - Law and legislation - United States
Drugs - Prices - Law and legislation - United States
Poor - Pharmaceutical assistance - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug discount program
Record Nr. UNINA-9910712952703321
[Washington, D.C.] : , : United States Government Accountability Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica 1 online resource (v, 136 pages) : illustrations
Soggetto topico User charges - Law and legislation
Prescription pricing - Law and legislation
Generic drugs - Prices
Drugs - Law and legislation
Generic drugs - Prices - United States
Prescription pricing - Law and legislation - United States
User charges - Law and legislation - United States
Drug accessibility - Government policy - United States
Drugs - Law and legislation - United States
Soggetto genere / forma Rules.
Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Examining FDA's generic drug and biosimilar user fee programs
Record Nr. UNINA-9910716666403321
Washington : , : U.S. Government Publishing Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica 1 online resource (v, 107 pages) : illustrations
Soggetto topico User charges - Law and legislation - United States
Drugs - Law and legislation - United States
Prescription pricing - Law and legislation - United States
Generic drugs - Prices - United States
Drug accessibility - Government policy - United States
Drug approval - United States
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Examining FDA's Prescription Drug User Fee program
Record Nr. UNINA-9910706847203321
Washington : , : U.S. Government Publishing Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui

Data di pubblicazione